NO20042256L - Rasemisk fri tamsulosinbase samt fremgangsmater ved fremstilling derav - Google Patents

Rasemisk fri tamsulosinbase samt fremgangsmater ved fremstilling derav

Info

Publication number
NO20042256L
NO20042256L NO20042256A NO20042256A NO20042256L NO 20042256 L NO20042256 L NO 20042256L NO 20042256 A NO20042256 A NO 20042256A NO 20042256 A NO20042256 A NO 20042256A NO 20042256 L NO20042256 L NO 20042256L
Authority
NO
Norway
Prior art keywords
preparation
methods
racemic free
tamsulosin base
tamsulosin
Prior art date
Application number
NO20042256A
Other languages
English (en)
Norwegian (no)
Inventor
Hans Jan Hoorn
Theodorus Hendricus Antonius Peters
Jaroslav Pis
Original Assignee
Synthon Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthon Bv filed Critical Synthon Bv
Publication of NO20042256L publication Critical patent/NO20042256L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/04Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C217/06Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted
    • C07C217/14Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring
    • C07C217/18Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted
    • C07C217/20Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted by halogen atoms, by trihalomethyl, nitro or nitroso groups, or by singly-bound oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/08Drugs for disorders of the urinary system of the prostate
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/42Separation; Purification; Stabilisation; Use of additives
    • C07C303/44Separation; Purification
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/30Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/37Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20042256A 2001-10-31 2004-06-01 Rasemisk fri tamsulosinbase samt fremgangsmater ved fremstilling derav NO20042256L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US33081701P 2001-10-31 2001-10-31
US10/208,009 US6835853B2 (en) 2001-10-31 2002-07-31 Process for resolution of tamsulosin and compounds, compositions, and processes associated therewith
PCT/NL2002/000660 WO2003037851A1 (en) 2001-10-31 2002-10-17 Racemic tamsulosin free base and methods of making the same

Publications (1)

Publication Number Publication Date
NO20042256L true NO20042256L (no) 2004-07-28

Family

ID=26902810

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20042256A NO20042256L (no) 2001-10-31 2004-06-01 Rasemisk fri tamsulosinbase samt fremgangsmater ved fremstilling derav

Country Status (17)

Country Link
US (2) US6835853B2 (xx)
EP (2) EP1444198A1 (xx)
CN (2) CN100343227C (xx)
AT (2) ATE417822T1 (xx)
AU (2) AU2002330774B9 (xx)
CA (2) CA2464648C (xx)
CH (3) CH697034A5 (xx)
CZ (2) CZ13392U1 (xx)
DE (3) DE60230438D1 (xx)
DK (2) DK200200338U3 (xx)
FI (2) FI5816U1 (xx)
FR (2) FR2832147B1 (xx)
IL (2) IL161449A0 (xx)
IS (2) IS6602A (xx)
NL (2) NL1021671C2 (xx)
NO (1) NO20042256L (xx)
WO (2) WO2003037850A1 (xx)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2200699B1 (es) * 2002-07-12 2005-10-01 Ragactives, S.L Procedimiento para la separacion de r(-) y s(+)-5-(2-((2-(etoxifenoxi)etil)amino)propil-2-metoxibenceno-sulfonamida.
USH2154H1 (en) * 2003-10-08 2006-04-04 Farmak, A.S. Process for preparing R- and S-isomers of (R)-5-(2-( (2-(2-ethoxyphenoxy)ethyl)amino)propyl)-2-methoxybenzenesulfonamide
SI21656A (sl) * 2003-12-29 2005-06-30 LEK farmacevtska družba d.d. Priprava (R)-5-(2-(2-(2-etoksifenoksi) etilamino)-1-propil)-2-metoksibenzensulfonamida hidroklorida z visoko kemijsko čistoto
SI21702A (en) * 2004-01-29 2005-08-31 Lek Farmacevtska Druzba Dd Preparation of amorphous form of tamsulosin
WO2005089511A2 (en) * 2004-03-19 2005-09-29 Transform Pharmaceuticals, Inc. Novel pharmaceutical forms, and methods of making and using the same
CN100545148C (zh) 2004-08-16 2009-09-30 神隆新加坡私人有限公司 一种抗良性前列腺肥大药物坦索罗辛之合成方法
US7238839B2 (en) 2004-10-07 2007-07-03 Divi's Laboratories Limited Process for the resolution of racemic (R,S) -5-(2-(2-(2- ethoxyphenoxy) ethylamino)Propyl)-2-methoxybenzene sulfonamide (tamsulosin), its novel R and S isomers and their salts and processes for their preparation
PT103216B (pt) 2004-12-06 2010-05-19 Hovione Farmaciencia S A Preparação de tamsulosin
WO2006117662A2 (en) * 2005-05-03 2006-11-09 Ranbaxy Laboratories Limited Polymorphic forms of (r)-(-)-tamsulosin
US20090137844A1 (en) * 2005-06-15 2009-05-28 Fermion Oy Crystallization process
EP2026766A1 (en) 2006-05-17 2009-02-25 Synthon B.V. Tablet composition with a prolonged release of tamsulosin
US20080312328A1 (en) * 2007-06-14 2008-12-18 Protia, Llc Deuterium-enriched tamsulosin
DE102008002409A1 (de) * 2008-06-13 2009-12-17 Evonik Goldschmidt Gmbh Enzymatische Synthese von Sphingolipiden
US8465770B2 (en) * 2008-12-24 2013-06-18 Synthon Bv Low dose controlled release tablet
EP2338876A1 (en) 2009-12-22 2011-06-29 LEK Pharmaceuticals d.d. Tamsulosin adipate for pharmaceutical use
KR101525493B1 (ko) * 2013-01-02 2015-06-03 보령제약 주식회사 고순도 탐술로신 또는 이의 염 제조방법
CN104926699B (zh) * 2015-07-02 2018-09-25 成都丽凯手性技术有限公司 一种高光学纯度盐酸坦索罗辛的制备方法
CN106631918B (zh) * 2016-10-13 2018-07-13 深圳万和制药有限公司 拆分坦索罗辛对映异构体的方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH383998A (de) * 1959-08-05 1964-11-15 Ciba Geigy Verfahren zur Herstellung neuer sekundärer Amine
US3261829A (en) * 1964-08-12 1966-07-19 Searle & Co Spiro(steroidal-6,3'-1-pyrazolines) and process
CA1147342A (en) 1977-10-12 1983-05-31 Kazuo Imai Process of producing novel phenylethanolamine derivatives
JPS56110665A (en) 1980-02-08 1981-09-01 Yamanouchi Pharmaceut Co Ltd Sulfamoyl-substituted phenetylamine derivative and its preparation
US5391825A (en) * 1980-02-08 1995-02-21 Yamanouchi Pharmaceutical Co., Ltd. Sulfamoyl substituted phenethylamine intermediates
JPH066565B2 (ja) 1986-07-21 1994-01-26 山之内製薬株式会社 光学活性なベンゼンスルホンアミド誘導体の製造法
ATE146775T1 (de) * 1993-02-23 1997-01-15 Hoechst Ag Substituierte benzolsulfonylharnstoffe und - thioharnstoffe- verfahren zu ihrer herstellung und ihre verwendung als pharmazeutika
US5877218A (en) * 1994-01-10 1999-03-02 Teva Pharmaceutical Industries, Ltd. Compositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivatives

Also Published As

Publication number Publication date
DK200200338U1 (da) 2003-01-31
DK200200338U3 (da) 2003-07-11
CH697164A5 (de) 2008-05-30
CN1578762A (zh) 2005-02-09
NL1021678C2 (nl) 2003-05-15
CZ13580U1 (cs) 2003-08-18
FR2832147A1 (fr) 2003-05-16
DE60230438D1 (de) 2009-01-29
AU2002330776B2 (en) 2009-03-12
DE20216835U1 (de) 2003-09-25
CA2464917A1 (en) 2003-05-08
IL161449A0 (en) 2004-09-27
IL161490A0 (en) 2004-09-27
CH696665A5 (de) 2007-09-14
AT6687U1 (de) 2004-02-25
FIU20020421U0 (fi) 2002-10-23
DK200200339U3 (da) 2003-06-13
AU2002330774B9 (en) 2010-01-07
EP1444199A1 (en) 2004-08-11
DE20216779U1 (de) 2003-09-04
CZ13392U1 (cs) 2003-06-24
EP1444198A1 (en) 2004-08-11
FIU20020420U0 (fi) 2002-10-23
FR2832146A1 (fr) 2003-05-16
WO2003037850A1 (en) 2003-05-08
CA2464917C (en) 2009-06-02
AU2002330774B2 (en) 2009-06-04
CN100343227C (zh) 2007-10-17
FI5816U1 (fi) 2003-06-06
FR2832146B1 (fr) 2006-05-26
IS6603A (is) 2003-05-02
WO2003037851A1 (en) 2003-05-08
ATE417822T1 (de) 2009-01-15
FI5957U1 (fi) 2003-09-30
US20050096394A1 (en) 2005-05-05
IS6602A (is) 2003-05-02
FR2832147B1 (fr) 2006-06-02
CN1578761A (zh) 2005-02-09
CN100579958C (zh) 2010-01-13
EP1444199B1 (en) 2008-12-17
DK200200339U1 (da) 2003-01-31
CA2464648C (en) 2009-07-14
CH697034A5 (de) 2008-03-31
US20030109752A1 (en) 2003-06-12
CA2464648A1 (en) 2003-05-08
NL1021671C2 (nl) 2003-05-15
US6965051B2 (en) 2005-11-15
US6835853B2 (en) 2004-12-28

Similar Documents

Publication Publication Date Title
NO20042256L (no) Rasemisk fri tamsulosinbase samt fremgangsmater ved fremstilling derav
DE60206344D1 (de) Baueinheit von Leuchten und Zubehör
FI20010644A (fi) Merkkisekvenssin kielen määrittäminen
ITMI20022233A1 (it) Apparecchiatura di ricezione-trasmissione e procedimento
DE60238206D1 (de) Frequenz- und amplitudenapodisierung von wandlern
DE60235896D1 (de) Verzögerte freigabe von mikrokristallin peptidsuspensionen
WO2003059257A8 (en) Anti-angiogenic proteins and fragmentsand methods of use thereof
NO20033854L (no) N-but-3-enyl-norbuprenorfin og fremgangsmåter for anvendelse
NO20033506D0 (no) Parasittdrepende preparater og fremgangsmåter for anvendelse
DE60217039D1 (de) Schaufelblattfuss- und Scheibennutkontur
DE50213942D1 (de) Eschichten von metallischen bauteilen
AU2002363938A8 (en) Methods and use of motoneuronotropic factors
DE60309255D1 (de) Abbildung und Entnahme von Gel
DE60232751D1 (de) Steckverbinder und Stecker
EP1407722A4 (en) PROSTHESIS BASE, ITS PREPARATION METHOD AND INSTRUMENT USED THEREIN
DK1366039T3 (da) Piperazinylcarbonylquinoliner og -isoquinoliner
HU0102942D0 (en) Device for base of polygon crossing piece
DE50203105D1 (de) Lagerung von entnahmeelementen
TW477454U (en) Saxophone capable of playing high octachord sol rapidly and precisely
SE0104404D0 (sv) New methods and use
DK200100290U3 (da) Indvendig konservering af bro- og fortøjringspæle
DE60224373D1 (de) Erfassung von objekten
ITBA20010029U1 (it) Gioiello di puglia
UA5410S (uk) Кадроплан поліекрана
ITCB20010002U1 (it) Depilazione pratica

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application